Citations

Showing 10 of 108094 citations.

Motor Responses of the Esophagus to Distention
Creamer, B., Schlegel, Jerry F.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 10 | Issue: 3 | Pages: 498-504

10.1152/jappl.1957.10.3.498 | PMID 13438808 Get It

Effects of ethanol, xylose, and glucose on canine jejunal motility
Charles, François , Phillips, S. F.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 269 | Issue: 3 | Pages: G363-G369

10.1152/ajpgi.1995.269.3.g363 | PMID 7573446 Get It

Ethanol is an important source of calories that can cause certain gastrointestinal symptoms, notably diarrhea. To examine the effects of ethanol on the small bowel, we intraluminally perfused the jejunum of four dogs with ethanol (18, 9, 4.5, and 1.5%, wt/vol), D-xylose (30, 15, 7.5, and 4.5%, wt/vol), or glucose (30 and 5%, wt/vol). In other experiments, these solutes were infused intravenously. Saline was always given by the alternate route; jejunal manometry was recorded during and after the infusions. Phase III of the interdigestive cycle was delayed by all intraluminal infusions except for 4.5 and 1.5% ethanol, 4.5% xylose, and 5% glucose. In addition, the onset of irregular contractile activity was delayed more with intraluminal ethanol than with intraluminal xylose or intraluminal glucose (P < 0.01). When administered intraluminally, ethanol and xylose appeared in blood but only ethanol equilibrated fully between the lumen and blood. Intravenous infusions of ethanol and xylose, but not glucose, also delayed the return of phase III. When given intravenously, ethanol and xylose were recovered from the lumen, whereas glucose never was. Ethanol and xylose had comparable effects on the canine small bowel; they induced prolonged periods of irregular contractile activity and delayed the return of phase III. These effects were seen rapidly when solutes were administered intraluminally and more slowly when they were given intravenously. These results suggest that local luminal mechanisms stimulated by solutes influence small bowel motility, and they imply that the gut recognizes solutes whether or not these molecules are metabolizable.
Simultaneous Cineradiographic and Kymographic Studies of Human Gastric Antral Motility
Smith, Alan W. M., Code, Charles F., Schlegel, Jerry F.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 11 | Issue: 1 | Pages: 12-16

10.1152/jappl.1957.11.1.12 | PMID 13462910 Get It

Dynamic Response Characteristics of Systems for Continuous Recording of Concentration Changes in a Flowing Liquid (for Example, Indicator-Dilution Curves)
Fox, Irwin J., Sutterer, William F., Wood, Earl H.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 11 | Issue: 3 | Pages: 390-404

10.1152/jappl.1957.11.3.390 | PMID 13480950 Get It

Revised Equations for Calculation of Blood Flow and Central Blood Volume From Indicator-Dilution Curves
Keys, John, Hetzel, Peter S., Wood, Earl H.

Mayo Clinic

Journal of Applied Physiology | December 24, 2017 | Volume: 11 | Issue: 3 | Pages: 385-389

10.1152/jappl.1957.11.3.385 | PMID 13480949 Get It

Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis
Jaiswal, Meeta, LaRusso, Nicholas F. , Gores, Gregory J.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 281 | Issue: 3 | Pages: G626-G634

10.1152/ajpgi.2001.281.3.g626 | PMID 11518674 Get It

Chronic inflammation of gastrointestinal tissues is a well-recognized risk factor for the development of epithelial cell-derived malignancies. Although the inflammatory mediators linking chronic inflammation to carcinogenesis are numerous, current information suggests that nitric oxide (NO) contributes to carcinogenesis during chronic inflammation. Inducible nitric oxide synthase (iNOS), expressed by both macrophages and epithelial cells during inflammation, generates the bioreactive molecule NO. In addition to causing DNA lesions, NO can directly interact with proteins by nitrosylation and nitosation reactions. The consequences of protein damage by NO appear to be procarcinogenic. For example, NO inhibits DNA repair enzymes such as human 8-oxodeoxyguanosine DNA glycosylase 1 and blocks apoptosis via nitrosylation of caspases. These cellular events permit DNA damage to accumulate, which is required for the numerous mutations necessary for development of invasive cancer. NO also promotes cancer progression by functioning as an angiogenesis factor. Strategies to inhibit NO generation during chronic inflammation or to scavenge reactive nitrogen species may prove useful in decreasing the risk of cancer development in chronic inflammatory gastrointestinal diseases.
Regulation of Cellular Growth by 1,25-Dihydroxyvitamin D3-Mediated Growth Factor Expression
Veenstra, Timothy D. , Pittelkow, Mark R. , Kumar, Rajiv , Kumar, Rajiv

Mayo Clinic

Physiology | December 24, 2017 | Volume: 14 | Issue: 1 | Pages: 37-40

10.1152/physiologyonline.1999.14.1.37 | PMID 11390816 Get It

Although the primary function of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the regulation of calcium and phosphorus metabolism, it also regulates the growth and differentiation of several different cell types. Recent work suggests that 1,25(OH)2D3 regulates cellular growth by altering the synthesis of growth factors and growth factor responses.
Effects of an α2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans
Viramontes, Blanca E., Malcolm, Allison , Camilleri, Michael , Szarka, Lawrence A., McKinzie, Sanna, Burton, Duane D. , Zinsmeister, Alan R., Malcolm, Allison

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 281 | Issue: 6 | Pages: G1468-G1476

10.1152/ajpgi.2001.281.6.g1468 | PMID 11705752 Get It

To characterize α2-adrenergic control of motor and sensory functions of gastrointestinal tract and colon, we studied dose-related effects of clonidine (placebo or up to 0.3 mg po) by random assignment in 55 healthy humans. Gastrointestinal transit was measured in all subjects; in 35, we assessed colonic compliance, tone, and sensations of gas and pain during phasic distensions. Clonidine did not significantly alter gastrointestinal or colonic transit, but it increased colonic compliance and reduced fasting tone without altering colonic response to a meal. Clonidine significantly reduced aggregate sensation to distensions overall and had significant linear dose-related sensory effects at 8- and 24-mmHg distensions. Effect on pain (including dose-response relationship) was due to 0.3-mg dose for distensions at 24 mmHg. We confirmed that clonidine relaxes fasting colonic tone and reduces sensation of pain. In this study, gut transit was not altered by clonidine, and novel dose-response characteristics and clonidine's effect on gas sensation are provided. Doses as low as 0.05 mg may be effective and potentially useful in reducing colonic tone and gas sensation.
Electrophysiological effects of nitric oxide in mouse superior mesenteric ganglion
Mazet, Bruno, Miller, Steven M. , Szurszewski, Joseph H.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 270 | Issue: 2 | Pages: G324-G331

10.1152/ajpgi.1996.270.2.g324 | PMID 8779975 Get It

Effects of nitric oxide (NO) generated from sodium nitroprusside (SNP) on neurons of mouse superior mesenteric ganglion (SMG) were studied in vitro using intracellular recording techniques. SNP solutions caused a membrane hyperpolarization in the majority (64%) of the neurons tested or a hyperpolarization followed by a depolarization in 8% of the neurons tested. The SNP-induced hyperpolarization persisted in a low-Ca2+ high-Mg2+ solution, indicating a direct effect of NO on the postsynaptic membrane. The hyperpolarizing effect of SNP was reduced or abolished by oxyhemoglobin. Electrical stimulation of the colonic nerves evoked a late slow excitatory postsynaptic potential (late sEPSP) in a population of neurons in normal Krebs solution. The amplitude of the late sEPSP was significantly enhanced in the presence of NG-nitroL-arginine, a NO synthase inhibitor. The results, particularly those observed with the NO synthase inhibitor, suggest that endogenous NO was released in the mouse SMG by repetitive nerve stimulation and that it modulated slow synaptic transmission, presumably by a direct action on ganglionic neurons.
A cascade of degradative hydrolase activity contributes to hepatocyte necrosis during anoxia
Arora, Amindra S., Groen, P. de, Emori, Yasufumi, Gores, G. J.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 270 | Issue: 2 | Pages: G238-G245

10.1152/ajpgi.1996.270.2.g238 | PMID 8779964 Get It

Calpain proteases contribute to hepatocyte necrosis during anoxia. Our aim was to ascertain the mechanism causing calpain activation during anoxia. In rat hepatocytes, a twofold increase in calpain activity occurred despite the lack of an increase in cytosolic Ca2+ concentration ([Ca2+]i). The increase in calpain activity was not associated with an increase in calpain mRNA or a decrease in calpastatin mRNA expression. Because phospholipid degradation products generated by phospholipases can activate calpains at physiological [Ca2+]i, we determined the effect of phospholipase inhibitors and activators on calpain activity. Pretreatment of hepatocytes with fluphenazine, a phospholipase inhibitor, decreased calpain activation and improved cell survival. Melittin, a phospholipase A2 activator, increased calpain activity and potentiated cell killing. Finally, phospholipid degradation preceded the increase in calpain activity. Thus the enhanced calpain activity occurring in hepatocytes during anoxia 1) is regulated at the posttranslational level and 2) appears to be dependent on phospholipase activity. These data suggest a novel cascade for degradative hydrolase activity during hepatocyte necrosis by anoxia with phospholipase-mediated activation of calpains.